» Articles » PMID: 6412235

A Canine Model of Human Alpha-L-iduronidase Deficiency

Overview
Specialty Science
Date 1983 Oct 1
PMID 6412235
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

A disease discovered in three Plott Hound littermates was found to be associated with a profound and specific deficiency of alpha-L-iduronidase (mucopolysaccharide alpha-L-iduronohydrolase; EC 3.2.1.76) in fibroblasts and leukocytes. The pedigree was consistent with autosomal recessive inheritance. A markedly increased amount of dermatan sulfate and heparan sulfate was excreted in urine. Fibroblasts cultured from the skin of the affected dogs accumulated excessive 35S-labeled mucopolysaccharide; this accumulation could be decreased to a normal level by exogenous human high-uptake alpha-L-iduronidase (Hurler corrective factor) as well as by secretions of normal human or canine fibroblasts. The correction was inhibited by mannose 6-phosphate. Maturation of alpha-L-iduronidase in normal canine fibroblasts followed the pathway previously observed in human fibroblasts; no cross-reactive material was observed in the cells or in secretions from the fibroblasts of the affected dogs. The canine disorder thus resembles mucopolysaccharidosis I in all biochemical parameters tested; the clinical appearance of the animals is closest to Hurler-Scheie syndrome, a form of alpha-L-iduronidase deficiency of intermediate severity. The animal model should prove valuable for therapeutic experiments.

Citing Articles

Evaluation of tendon and ligament microstructure and mechanical properties in a canine model of mucopolysaccharidosis I.

Lau Y, Iyer K, Shetye S, Friday C, Dodge G, Hast M J Orthop Res. 2024; 42(7):1409-1419.

PMID: 38368531 PMC: 11161329. DOI: 10.1002/jor.25813.


Proteomics identifies novel biomarkers of synovial joint disease in a canine model of mucopolysaccharidosis I.

Zhang C, Gawri R, Lau Y, Spruce L, Fazelinia H, Jiang Z Mol Genet Metab. 2023; 138(2):107371.

PMID: 36709534 PMC: 9918716. DOI: 10.1016/j.ymgme.2023.107371.


Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders.

Placci M, Giannotti M, Muro S Adv Drug Deliv Rev. 2023; 197:114683.

PMID: 36657645 PMC: 10629597. DOI: 10.1016/j.addr.2022.114683.


Effects of lithium administration on vertebral bone disease in mucopolysaccharidosis I dogs.

Lau Y, Peck S, Arginteanu T, Wu M, Lin M, Shore E Bone. 2021; 154:116237.

PMID: 34695616 PMC: 8671266. DOI: 10.1016/j.bone.2021.116237.


Differences in MPS I and MPS II Disease Manifestations.

Hampe C, Yund B, Orchard P, Lund T, Wesley J, McIvor R Int J Mol Sci. 2021; 22(15).

PMID: 34360653 PMC: 8345985. DOI: 10.3390/ijms22157888.


References
1.
Fratantoni J, Hall C, Neufeld E . The defect in Hurler's and Hunter's syndromes: faulty degradation of mucopolysaccharide. Proc Natl Acad Sci U S A. 1968; 60(2):699-706. PMC: 225102. DOI: 10.1073/pnas.60.2.699. View

2.
Gorham L, WAYMOUTH C . DIFFERENTIATION IN VITRO OF EMBRYONIC CARTILAGE AND BONE IN A CHEMICALLY-DEFINED MEDIUM. Proc Soc Exp Biol Med. 1965; 119:287-90. DOI: 10.3181/00379727-119-30160. View

3.
Baker Jr H, Lindsey J, McKhann G, FARRELL D . Neuronal GM1 gangliosidosis in a Siamese cat with beta-galactosidase deficiency. Science. 1971; 174(4011):838-9. DOI: 10.1126/science.174.4011.838. View

4.
Barton R, Neufeld E . The Hurler corrective factor. Purification and some properties. J Biol Chem. 1971; 246(24):7773-9. View

5.
Hocking J, Jolly R, Batt R . Deficiency of alpha-mannosidase in Angus cattle. An inherited lysosomal storage disease. Biochem J. 1972; 128(1):69-78. PMC: 1173571. DOI: 10.1042/bj1280069. View